Pharmaust
- Short interest
- 0.02%
- −0.02 pp 30d
- as of 14 Oct 2024
- Reported shorts
- 108.1K
- Shares on issue
- 486.635M
Pharmaust (PAA) Short Interest
Pharmaust (ASX:PAA) had 0.02% of shares reported as short positions as of 14 Oct 2024, representing 108,089 shares. Pharmaust operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Pharmaust
To develop its own drug discovery intellectual property for the treatment of different types of neurological diseases
Company profile →Pharmaust (ASX:PAA) has 0.02% of its shares on issue reported as short positions as of 14 Oct 2024, or about 108,089 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.09% in May 2023. PAA is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Company details
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss PAA
Start a research thread or post the first pulse update